Readmissions are often treated as a discharge planning issue when they are just as much a documentation problem. For fiscal year (FY) 2027, the Centers for Medicare & Medicaid Services (CMS) is penalizing 2,334 hospitals under the Hospital Readmissions Reduction Program (HRRP), which is about 80 percent of those evaluated, according to Becker’s Hospital Review, up from 2,304 hospitals (78 percent) in FY 2026, as reported by Healthcare Dive.
The reductions took effect Oct. 1, and they apply to the base operating MS-DRG payment for every traditional Medicare inpatient stay for the entire year, not just the readmissions. Even a penalty below 1 percent, applied to a full year of traditional Medicare inpatient payments, can be the difference between a positive and a negative margin.
The distribution matters, too. This year, 244 hospitals (8.4 percent) face penalties of 1 percent or more, up from 240 (8.1 percent) last year. Ten hospitals were penalized at the maximum at 3 percent, and 34 face penalties of 2 percent or more. Only 578 hospitals (19.8 percent) escaped a penalty entirely, down from 641 (21.8 percent), while 71.8 percent face penalties below 1 percent.
HRRP was created by the Patient Protection and Affordable Care Act (PPACA) and has reduced payments to Inpatient Prospective Payment System (IPPS) hospitals for excess readmissions since FY 2013. It currently scores six condition and procedure measures: acute myocardial infarction (AMI), chronic obstructive pulmonary disease (COPD), heart failure, pneumonia, coronary artery bypass graft (CABG) surgery, and elective total hip and knee arthroplasty.
A measure counts only when a hospital has at least 25 eligible discharges in the performance period. Only subsection (d) hospitals, those paid under the IPPS, are required to participate in HRRP.
For each measure, CMS calculates an excess readmission ratio (ERR) by dividing a hospital’s predicted readmissions by its expected readmissions, both derived from a risk-adjustment model that accounts for age, sex, and comorbidities. Since FY 2019, the 21st Century Cures Act has required CMS to compare each hospital to the median ERR of a peer group with a similar proportion of dual-eligible patients, rather than to a national average. The penalty is capped at 3 percent.
Here is the part that frustrates hospital leaders: because performance is judged against a peer group median that moves every year, how can a hospital ever be sure that improving its own readmission rate will reduce its penalty? It cannot.
What it can control, along with the quality of its care transitions, is how accurately its patients’ severity is represented in the data. This is why many hospitals have incorporated risk-adjustment reviews into their clinical documentation integrity (CDI) workflow.
According to the CMS FY 2027 HRRP fact sheet, this is the first year performance includes Medicare Advantage (MA) beneficiaries alongside traditional Medicare beneficiaries, although the penalty is still applied only to traditional Medicare payments. CMS also shortened the performance period from three years to two (discharges from July 1, 2023, to June 30, 2025) and removed the COVID-19 exclusion.
Even with a shorter window, Becker’s analysis found the number of discharges behind the scores rose 53 percent to 3.88 million. A shorter window paired with a larger population means recent performance, good or bad, moves the penalty faster.
More change is coming. In the FY 2027 IPPS Final Rule, CMS finalized a seventh measure: a 30-day readmission measure following sepsis hospitalization, beginning with the FY 2030 program year. Hospitals will receive confidential early-look reports in FY 2028 and FY 2029, but the FY 2030 performance period runs from July 1, 2026 to June 30, 2028. In other words, the sepsis cases being documented and coded today will count toward a future payment reduction. Because hospitals define sepsis differently, with some using Systemic Inflammatory Response Syndrome (SIRS) criteria plus infection (Sepsis-2) and others requiring infection plus organ dysfunction (Sepsis-3), the patients who enter this measure are likely to vary significantly from hospital to hospital, which may affect overall performance.
Readmissions are also tracked through the Hospital Inpatient Quality Reporting (IQR) Program Hybrid Hospital-Wide Readmission (HWR) measure. Unlike HRRP, the HWR is pay-for-reporting, counts any unplanned readmission for any cause to any acute-care hospital, and blends five specialty cohorts into a single publicly reported rate. Submission of the hybrid measure core clinical data elements (CCDEs) from the electronic health record (EHR) was voluntary for FY 2027 but is required beginning with the FY 2028 payment determination.
The first mandatory deadline, covering discharges from July 1, 2025, to June 30, 2026, was Oct. 1, 2026. Although CMS has not proposed it, it is likely that it is testing this methodology, and if successful, could transition to it within HRRP.
Observation stays are excluded from both the numerator and denominator of the readmission measures, which creates an obvious temptation. Let me be clear: hospitals should not place patients in observation status for the purpose of preventing readmissions. Patient status is a clinical determination under the Two-Midnight Rule at 42 CFR 412.3, based on the expected need for medically necessary hospital care. If the record supports an inpatient admission, documenting observation to protect a quality score is a compliance risk, not a quality improvement.
This is not a hypothetical concern. The Center for Medicare Advocacy summarized research finding that observation stays accounted for 40 percent of the readmission reductions originally credited to HRRP, and that observation patients were clinically indistinguishable from short inpatient admissions. The patient also pays the price, often through higher out-of-pocket costs, and observation days do not count toward the three-day inpatient stay required for Medicare coverage of skilled nursing facility (SNF) care.
CDI cannot change the readmission itself, but it has significant influence over the expected side of the ratio. When comorbidities are not documented and coded, the risk model treats the patient as healthier than they were, which lowers the expected readmissions and inflates the ERR.
The model looks back at diagnoses on the index admission and on Medicare claims from the prior 12 months, but conditions that may be complications of the index stay are not counted as risk factors, which is why accurate present-on-admission (POA) indicators matter. With MA patients now in the measure population, every index admission for these conditions matters, whether the patient has traditional Medicare or MA.
I recommend CDI departments start with four steps. First, prioritize complete and clinically valid capture of comorbidities and severity on index admissions for the HRRP conditions. Second, get the principal diagnosis right the first time; it determines whether a stay is even in a measure cohort. Sequencing must always follow the ICD-10-CM Official Guidelines, never a desire to move a case into or out of a measure. Third, treat sepsis as a current priority, since the FY 2030 performance period is already underway, and make clinical validation of sepsis consistent across your organization. Fourth, review your Hospital-Specific Report with CDI, coding, quality, case management, utilization review, and your physician advisor(s) so everyone understands which measures are driving the penalty.
Readmission penalties are no longer a small line item for a few outlier hospitals; they reach eight out of 10. The question for CDI leaders is not whether your hospital is being measured, but whether the data CMS is measuring tells the true story of how sick your patients really are.

















